Medical/Pharmaceuticals

U.S. Patient with Advanced Lung Cancer Stabilized by Novel Immunotherapy Treatment in China

SHANGHAI, March 7, 2026 /PRNewswire/ -- Jiahui International Cancer Center (JICC) has stabilized a U.S. patient with advanced non‑small cell lung cancer (NSCLC) and Parkinson's disease using ivonescimab, a novel immunotherapy currently available only in China.

2026-03-07 13:12 1703

Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio

* Acquisition positions Servier as a leader in pediatric low-grade glioma and expands its pipeline with programs targeting adult and pediatric cancers with high unmet needs.  * Transaction represents total equity value of approximately $2.5 billion. SURESNES, France and BRISBANE, Calif., Marc...

2026-03-07 02:30 4486

Sciwind Biosciences Announces Ecnoglutide Injection Approved by China's National Medical Products Administration (NMPA) for Chronic Weight Management

HANGZHOU, China, March 6, 2026 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind"), a biopharmaceutical company focused on the discovery and development of innovative therapies for metabolic diseases, announced today that China's National Medical Products Administration (NMPA) has ...

2026-03-06 14:39 2353

Ceretone Launches in Australia with Flagship Core One Pro, Revolutionizing Access to Premium Hearing Solutions

MELBOURNE, Australia, March 6, 2026 /PRNewswire/ -- Ceretone , an innovative hearing technology brand, today announces its official entry into the Australian market. The company's comprehensive product line will launch on Chemist Warehouse's online platform in late Febr...

2026-03-06 08:00 853

The world's largest brain research prize awarded for groundbreaking discoveries on how we sense touch and pain

The Brain Prize 2026 is awarded to Professors David Ginty (US) and Patrik Ernfors (Sweden) for their pioneering discoveries on how the nervous system detects and processes touch and pain. Their work has rewritten textbooks and opened new avenues for the development of targeted treatments for cond...

2026-03-05 23:00

Terumo Blood and Cell Technologies introduces APAC C> Ecosystem Blueprint

A collaborative integration model to enable practical, scalable cell and gene therapy delivery. SINGAPORE, March 5, 2026 /PRNewswire/ -- Terumo Blood and Cell Technologies (Terumo BCT) today announced the launch of its new C> Ecosystem Blueprint — a practical, collaborative approach designed t...

2026-03-05 10:10 2013

Empowering the SBMA Community: AnnJi Highlights Patient & Family Forum and Shares AJ201 Scientific Advancement at the 2026 KDA Conference

TAIPEI, March 4, 2026 /PRNewswire/ -- AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) announced its participation in the 2026 International Patient and Scientific Conference hosted by the Kennedy's Disease Association (KDA). Held between February 27 and March 2, the conference served as a prem...

2026-03-05 09:47 1933

MGI Tech Announces Acquisition of STOmics and CycloneSEQ to Deliver Integrated Long-Read, Short-Read and Spatial Omics Solutions

SHENZHEN, China, March 4, 2026 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in the life sciences, today announced the acquisition of STOmics and CycloneSEQ. It marks a significant milestone in MGI's "SEQALL+GLI+Omi...

2026-03-04 11:58 2906

Gene Solutions Announces Strategic Entry into Türkiye with Robust Real-World Evidence at the 2nd International Hereditary Cancers Congress 2026

In Partnership with ATC Genomics, the Company Presented One of Asia's Largest Real-World Datasets (n=12,281) for AI-Powered Multi-Cancer Early Detection (MCED) and Showcased its Clinically Validated ctDNA-Powered Oncology Portfolio Across the Full Cancer Continuum for High-Risk and Hereditary Pop...

2026-03-04 10:00 3345

PROTECTHEALTH STRENGTHENS GOVERNANCE AND SERVICE CONTINUITY WITH ISO 22301 BCMS CERTIFICATION

CYBERJAYA, Malaysia, March 4, 2026 /PRNewswire/ -- ProtectHealth Corporation Sdn. Bhd. has reinforced its role as a key government agency and strategic purchaser of healthcare services with the successful attainment of the ISO 22301:2019/AMD1:2024 Business Continuity Management System (BCMS) Cert...

2026-03-04 08:44 2198

Antengene and UCB Enter Global License Agreement for ATG-201, a CD19/CD3 Bispecific T-Cell Engager for Autoimmune Diseases

* Antengene grants UCB worldwide exclusive rights to develop, manufacture and commercialize ATG-201, a CD19/CD3 bispecific T-cell engager (TCE) antibody, targeting B cell-related autoimmune diseases. * Antengene will receive USD 80 million of upfront and near-term milestone payments, and is e...

2026-03-04 06:00 2663

HiRO Leads Cross‑Border Dialogue at JPM, Offering Insights for Biotechs Seeking Asian Investment

SOMERSET, N.J., March 3, 2026 /PRNewswire/ -- Harvest Integrated Research Organization (HiRO), a global contract research organization specializing in strategic planning for clinical development and cross‑border clinical trial solutions and services, concluded a successful presence at the 44th An...

2026-03-03 22:30 2729

REPROCELL Launches GMP Master Cell Bank Manufacturing for Clinical iPSCs

Integrated Workflow Including Clinical Seed Production and StemEdit Gene Editing Services BELTSVILLE, Md., March 3, 2026 /PRNewswire/ -- REPROCELL (TYO: 4978) today announced the launch of its US FDA compliant Good Manufacturing Practice (GMP) Master Cell Bank (MCB) manufacturing service for hum...

2026-03-03 22:00 2232

Rosti Asia 2025 Review & 2026 Outlook: Building on Shared Success

SINGAPORE, March 3, 2026 /PRNewswire/ -- A report from Ringiertrade. Pat Williams, Senior Vice President of Rosti Asia, writes how Rosti Asia has performed strongly across its markets in 2025 despite challenges, as it looks forward to new opportunities in 2026. 2025 was a year of resilience, col...

2026-03-03 15:12 2952

Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China

* First glucokinase-activator (GKA) approval outside mainland China * Approval supports a differentiated approach to Type 2 diabetes (T2D) management * Hong Kong will serve as Hua Medicine's launchpad for international market expansion SHANGHAI and HONG KONG, March 3, 2026 /PRNewswire/ -- Hu...

2026-03-03 13:58 3707

/C O R R E C T I O N -- CooperVision, Inc./

In the news release, CooperVision Expands MyDay® MiSight® 1 day Myopia Control Soft Contact Lenses Into Asia Pacific Region, issued 02-Mar-2026 by CooperVision, Inc. over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with addition...

2026-03-03 10:27 4990

Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform

NEW YORK, March 3, 2026 /PRNewswire/ -- Royalty Pharma plc (Nasdaq: RPRX) announced the appointment of Kenneth Sun as Senior Vice President and Head of Asia, effective May 2026. Ken will be based in Hong Kong and lead the company's royalty business in Asia. Ken joins Royalty Pharma from Morgan St...

2026-03-03 10:15 3272

Bright Eye Clinic Achieves Government Accreditation Amid Korea's Medical Tourism Growth

SEOUL, South Korea, March 3, 2026 /PRNewswire/ -- Bright Eye Clinic announced its official accreditation under theKorean Accreditation Program for Hospitals Serving Foreign Patients (KAHF), administered by the Korea Health Industry Development Institute (KHIDI) ...

2026-03-03 10:00 2597

AsiaMedic Delivers Improved FY2025 Performance as Core Imaging Business Strengthens

* Financial performance strengthened alongside business expansion as newly added capacity are ramped up during the year * Profit attributable to owners of the Company doubled to S$2.0 million in FY2025 * Disposal of 60% interest in aesthetic business sharpens focus on core healthcare operat...

2026-03-03 09:40 3262

Efor strengthens its presence in Asia with the acquisition of No deviation

LYON, France, March 3, 2026 /PRNewswire/ -- Efor, a global leader specializing in quality and compliance for the Life Sciences industry, announces the acquisition of Singapore-based No deviation, a company recognized for its expertise in Commissioning, Qualification & Validation (CQV), Computer S...

2026-03-03 09:00 2663
12345 ... 394

Week's Top Stories